I am an Assistant Attending Physicist in the Department of Medical Physics. My research work is focused on the development of novel MRI acquisition and reconstruction methodology using AI techniques to reduce scan time while preserving imaging quality, enabling free-breathing scans with increased image quality for cancer applications, including detection, diagnosis, and treatment response evaluation. I am actively pursuing clinical translation in collaboration with industrial partners.
My prior experience includes developing research projects in medical imaging, image processing, and machine learning in the U.S. and Peru. I was an associate at Harvard University and served as a director on the team that established the Universidad de Ingeniería y Tecnología (UTEC) in Peru.
Disclosures
Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.
MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.
Victor Murray discloses the following relationships and financial interests:
-
Aclara Resources Inc.
Professional Services and Activities
-
Metaphos Technology, Inc.
Equity; Professional Services and Activities
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
View all disclosures